These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22222677)

  • 1. Molecular basis of arterial stiffening: role of glycation - a mini-review.
    Sell DR; Monnier VM
    Gerontology; 2012; 58(3):227-37. PubMed ID: 22222677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ageing of the conduit arteries.
    Greenwald SE
    J Pathol; 2007 Jan; 211(2):157-72. PubMed ID: 17200940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular aging: from molecular mechanism to clinical significance.
    Sawabe M
    Geriatr Gerontol Int; 2010 Jul; 10 Suppl 1():S213-20. PubMed ID: 20590836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes.
    Aronson D
    J Hypertens; 2003 Jan; 21(1):3-12. PubMed ID: 12544424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-link breakers as a new therapeutic approach to cardiovascular disease.
    Susic D
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):853-6. PubMed ID: 17956231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
    Monnier VM; Mustata GT; Biemel KL; Reihl O; Lederer MO; Zhenyu D; Sell DR
    Ann N Y Acad Sci; 2005 Jun; 1043():533-44. PubMed ID: 16037276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation.
    Wu ET; Liang JT; Wu MS; Chang KC
    Exp Gerontol; 2011 Jun; 46(6):482-8. PubMed ID: 21316441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-products and arterial stiffness in hypertension.
    McNulty M; Mahmud A; Feely J
    Am J Hypertens; 2007 Mar; 20(3):242-7. PubMed ID: 17324733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of AST-120 (Kremezin) is a promising therapeutic strategy for advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Matsui T; Inoue H; Takeuchi M
    Med Hypotheses; 2007; 69(3):666-8. PubMed ID: 17331665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in the glycation of human aortic elastin.
    Konova E; Baydanoff S; Atanasova M; Velkova A
    Exp Gerontol; 2004 Feb; 39(2):249-54. PubMed ID: 15036419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age- and diabetes-related nonenzymatic crosslinks in collagen fibrils: candidate amino acids involved in Advanced Glycation End-products.
    Gautieri A; Redaelli A; Buehler MJ; Vesentini S
    Matrix Biol; 2014 Feb; 34():89-95. PubMed ID: 24060753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.
    Glenn JV; Mahaffy H; Wu K; Smith G; Nagai R; Simpson DA; Boulton ME; Stitt AW
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):441-51. PubMed ID: 18676633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular stiffening and arterial compliance. Implications for systolic blood pressure.
    Schiffrin EL
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):39S-48S. PubMed ID: 15607434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced nonenzymatic glycation endproducts (AGE): their relevance to aging and the pathogenesis of late diabetic complications.
    Sensi M; Pricci F; Andreani D; Di Mario U
    Diabetes Res; 1991 Jan; 16(1):1-9. PubMed ID: 1818791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics, formation, and pathophysiology of glucosepane: a major protein cross-link.
    Sjöberg JS; Bulterijs S
    Rejuvenation Res; 2009 Apr; 12(2):137-48. PubMed ID: 19415980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(5):953-5. PubMed ID: 15996828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the Maillard reaction on the physical properties and cell interactions of collagen.
    Avery NC; Bailey AJ
    Pathol Biol (Paris); 2006 Sep; 54(7):387-95. PubMed ID: 16962252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural strain energy function applied to the ageing of the human aorta.
    Zulliger MA; Stergiopulos N
    J Biomech; 2007; 40(14):3061-9. PubMed ID: 17822709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.